Novo’s Chief to Retire, Veteran Joergensen to Succeed HimBy
Joergensen to take over Jan. 1 after 25 years at the company
Soerensen will get nominated for seat on Novo A/S board
Novo Nordisk A/S, the world’s biggest maker of insulin, said Chief Executive Officer Lars Rebien Soerensen will retire by the end of 2016, unexpectedly early, after 16 years at the helm.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.